- Home
- IMMP vs ICG Comparison
IMMP vs ICG Comparison
Compare IMMP & ICG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- ICG
- Stock Information
- Founded
- IMMP 1987
- ICG 2017
- Country
- IMMP Australia
- ICG China
- Employees
- IMMP N/A
- ICG N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- ICG Semiconductors
- Sector
- IMMP Health Care
- ICG Technology
- Exchange
- IMMP Nasdaq
- ICG Nasdaq
- Market Cap
- IMMP 211.1M
- ICG 230.3M
- IPO Year
- IMMP N/A
- ICG 2023
- Fundamental
- Price
- IMMP $1.89
- ICG $2.72
- Analyst Decision
- IMMP Buy
- ICG Strong Buy
- Analyst Count
- IMMP 2
- ICG 2
- Target Price
- IMMP $8.50
- ICG $9.50
- AVG Volume (30 Days)
- IMMP 659.8K
- ICG 27.5K
- Earning Date
- IMMP 05-23-2025
- ICG 05-22-2025
- Dividend Yield
- IMMP N/A
- ICG N/A
- EPS Growth
- IMMP N/A
- ICG N/A
- EPS
- IMMP N/A
- ICG 0.12
- Revenue
- IMMP $3,019,249.00
- ICG $38,602,978.00
- Revenue This Year
- IMMP $50.37
- ICG N/A
- Revenue Next Year
- IMMP N/A
- ICG $147.04
- P/E Ratio
- IMMP N/A
- ICG $22.18
- Revenue Growth
- IMMP 24.11
- ICG 242.68
- 52 Week Low
- IMMP $1.32
- ICG $1.40
- 52 Week High
- IMMP $3.34
- ICG $12.04
- Technical
- Relative Strength Index (RSI)
- IMMP 54.39
- ICG 62.71
- Support Level
- IMMP $1.78
- ICG $2.01
- Resistance Level
- IMMP $2.71
- ICG $2.56
- Average True Range (ATR)
- IMMP 0.17
- ICG 0.24
- MACD
- IMMP 0.02
- ICG 0.14
- Stochastic Oscillator
- IMMP 25.45
- ICG 72.72
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About ICG Intchains Group Limited
Intchains Group Ltd provides integrated solutions consisting of high-performance ASIC chips and ancillary software and hardware for blockchain applications. Its ASIC chips are designed for several key blockchain algorithms including Blake2bsha3, sha512MD160, Cryptonight V4, Eaglesong, Blake2s and others. The company has built a proprietary technology platform named Xihe Platform, which allows the development of a wide range of ASIC chips with high efficiency and scalability. It designs its ASIC chips in-house, which enables it to leverage proprietary silicon data to deliver products reflecting the latest technological developments.